{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:22:16Z","timestamp":1782537736683,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010686","name":"H2020 European Institute of Innovation and Technology","doi-asserted-by":"publisher","award":["666992"],"award-info":[{"award-number":["666992"]}],"id":[{"id":"10.13039\/100010686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Understanding the earliest manifestations of Alzheimer\u2019s disease (AD) is key to realising disease-modifying treatments. Advances in neuroimaging and fluid biomarkers have improved our ability to identify AD pathology in vivo. The critical next step is improved detection and staging of early cognitive change. We studied an asymptomatic familial Alzheimer\u2019s disease (FAD) cohort to characterise preclinical cognitive change.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data included 35 asymptomatic participants at 50% risk of carrying a pathogenic FAD mutation. Participants completed a multi-domain neuropsychology battery. After accounting for sex, age and education, we used event-based modelling to estimate the sequence of cognitive decline in presymptomatic FAD, and uncertainty in the sequence. We assigned individuals to their most likely model stage of cumulative cognitive decline, given their data. Linear regression of estimated years to symptom onset against model stage was used to estimate the timing of preclinical cognitive decline.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Cognitive change in mutation carriers was first detected in measures of accelerated long-term forgetting, up to 10\u2009years before estimated symptom onset. Measures of subjective cognitive decline also revealed early abnormalities. Our data-driven model demonstrated subtle cognitive impairment across multiple cognitive domains in clinically normal individuals on the AD continuum.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Data-driven modelling of neuropsychological test scores has potential to differentiate cognitive decline from cognitive stability and to estimate a fine-grained sequence of decline across cognitive domains and functions, in the preclinical phase of Alzheimer\u2019s disease. This can improve the design of future presymptomatic trials by informing enrichment strategies and guiding the selection of outcome measures.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-020-00695-2","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:02:41Z","timestamp":1602028961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer\u2019s disease: a retrospective cohort analysis"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4467-128X","authenticated-orcid":false,"given":"Antoinette","family":"O\u2019Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S. J.","family":"Weston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanna M.","family":"Pavisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica D.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian J.","family":"Crutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick C.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil P.","family":"Oxtoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"issue":"1","key":"695_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"CEI Szoeke","year":"2019","unstructured":"GBD 2016 Dementia Collaborators E, Szoeke CEI, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, et al. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88\u2013106.","journal-title":"Lancet Neurol"},{"issue":"228","key":"695_CR2","doi-asserted-by":"publisher","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","volume":"6","author":"RA Sperling","year":"2014","unstructured":"Sperling RA, Rentz DM, Johnson KA, Karlawish J, Donohue M, Salmon DP, et al. The A4 study: stopping AD before symptoms begin? Sci Transl Med. 2014;6(228):228fs13.","journal-title":"Sci Transl Med"},{"issue":"30","key":"695_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"3679367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;3679367(30):795\u2013804.","journal-title":"N Engl J Med"},{"key":"695_CR4","volume-title":"Early Alzheimer\u2019s disease: developing drugs for treatment guidance for industry","author":"Fda, Cder, Mccrayk","year":"2018","unstructured":"Fda, Cder, Mccrayk. Early Alzheimer\u2019s disease: developing drugs for treatment guidance for industry 2018;."},{"issue":"5226","key":"695_CR5","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad E, Wasco W, Poorkaj P, Romano D, Oshima J, Pettingell W, et al. Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus. Science (80- ). 1995;269(5226):973\u20137.","journal-title":"Science (80- )"},{"issue":"6534","key":"695_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature. 1995;375(6534):754\u201360.","journal-title":"Nature."},{"issue":"6311","key":"695_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349(6311):704\u20136.","journal-title":"Nature."},{"issue":"4","key":"695_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/neup.12205","volume":"35","author":"NJ Cairns","year":"2015","unstructured":"Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, et al. Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology. 2015;35(4):390\u2013400.","journal-title":"Neuropathology."},{"issue":"1","key":"695_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt59","volume":"3","author":"RJ Bateman","year":"2010","unstructured":"Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, et al. Autosomal-dominant Alzheimer\u2019s disease: a review and proposal for the prevention of Alzheimer\u2019s disease. Alzheimers Res Ther. 2010;3(1):1.","journal-title":"Alzheimers Res Ther"},{"key":"695_CR10","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/brain\/121.9.1631","volume":"121","author":"NC Fox","year":"1998","unstructured":"Fox NC, Warrington EK, Seiffer AL, Agnew SK, Rossor MN, Rossor MN. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer\u2019s disease. A longitudinal prospective study. Brain. 1998;121:1631\u20139.","journal-title":"Brain."},{"issue":"1","key":"695_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1037\/neu0000030","volume":"28","author":"M Storandt","year":"2014","unstructured":"Storandt M, Balota DA, Aschenbrenner AJ, Morris JC. Clinical and psychological characteristics of the initial cohort of the dominantly inherited alzheimer network (DIAN). Neuropsychology. 2014;28(1):19\u201329.","journal-title":"Neuropsychology."},{"issue":"4","key":"695_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1001\/jamaneurol.2015.4851","volume":"73","author":"DC Aguirre-Acevedo","year":"2016","unstructured":"Aguirre-Acevedo DC, Lopera F, Henao E, Tirado V, Mu\u00f1oz C, Giraldo M, et al. Cognitive decline in a Colombian kindred with autosomal dominant Alzheimer disease: a retrospective cohort study. JAMA Neurol. 2016;73(4):431\u20138.","journal-title":"JAMA Neurol."},{"issue":"6","key":"695_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.21111","volume":"61","author":"CR Butler","year":"2007","unstructured":"Butler CR, Graham KS, Hodges JR, Kapur N, Wardlaw JM, Zeman AZJ. The syndrome of transient epileptic amnesia. Ann Neurol. 2007;61(6):587\u201398.","journal-title":"Ann Neurol"},{"issue":"2","key":"695_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(17)30434-9","volume":"17","author":"PSJ Weston","year":"2018","unstructured":"Weston PSJ, Nicholas JM, Henley SMD, Liang Y, Macpherson K, Donnachie E, et al. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer\u2019s disease: a cross-sectional study. Lancet Neurol. 2018;17(2):123\u201332.","journal-title":"Lancet Neurol"},{"issue":"5","key":"695_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1474-4422(18)30078-4","volume":"17","author":"JF Zimmermann","year":"2018","unstructured":"Zimmermann JF, Butler CR. Accelerated long-term forgetting in asymptomatic APOE \u03b54 carriers. Lancet Neurol. 2018;17(5):394\u20135.","journal-title":"Lancet Neurol"},{"issue":"11","key":"695_CR16","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134.","journal-title":"Neurology."},{"key":"695_CR17","volume-title":"Wechsler Adult Intelligence Scale -Revised","author":"D Weschler","year":"1981","unstructured":"Weschler D. Wechsler Adult Intelligence Scale -Revised. New York: Psychological Corporation; 1981."},{"key":"695_CR18","unstructured":"The National Adult Reading Test (NART) H a z e l E. N e l s o n w i t h J o n a t h a n W i l l i s o n Hazel E Nelson Part I: The Original Study NART and WAIS (1982)."},{"issue":"3","key":"695_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"key":"695_CR20","volume-title":"Recognition Memory Test: Rmt.(Words). Test Booklet 1","author":"E Warrington","year":"1984","unstructured":"Warrington E. Recognition Memory Test: Rmt.(Words). Test Booklet 1; 1984."},{"key":"695_CR21","unstructured":"Warrington EK. The Camden memory tests : manual: Psychology Press; 1996. p. 16."},{"issue":"2","key":"695_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3233\/JAD-132027","volume":"41","author":"L Rami","year":"2014","unstructured":"Rami L, Mollica MA, Garc\u00eda-Sanchez C, Salda\u00f1a J, Sanchez B, Sala I, et al. The Subjective Cognitive Decline Questionnaire (SCD-Q): a validation study. J Alzheimers Dis. 2014;41(2):453\u201366.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"695_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1037\/h0054651","volume":"18","author":"JR Stroop","year":"1935","unstructured":"Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643\u201362.","journal-title":"J Exp Psychol"},{"issue":"4","key":"695_CR24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0010-9452(86)80020-X","volume":"22","author":"M Jackson","year":"1986","unstructured":"Jackson M, Warrington EK. Arithmetic skills in patients with unilateral cerebral lesions. Cortex. 1986 Dec 1;22(4):611\u201320.","journal-title":"Cortex."},{"key":"695_CR25","doi-asserted-by":"crossref","unstructured":"Firth NC, Primativo S, Brotherhood E, Young AL, Yong KXX, Crutch SJ, et al. Sequences of cognitive decline in typical Alzheimer\u2019s disease and posterior cortical atrophy estimated using a novel event-based model of disease progression. Alzheimer\u2019s Dement. 2020;alz.12083.","DOI":"10.1002\/alz.12083"},{"issue":"3","key":"695_CR26","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.neuroimage.2012.01.062","volume":"60","author":"HM Fonteijn","year":"2012","unstructured":"Fonteijn HM, Modat M, Clarkson MJ, Barnes J, Lehmann M, Hobbs NZ, et al. An event-based model for disease progression and its application in familial Alzheimer\u2019s disease and Huntington\u2019s disease. Neuroimage. 2012;60(3):1880\u20139.","journal-title":"Neuroimage."},{"issue":"Pt 9","key":"695_CR27","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/brain\/awu176","volume":"137","author":"AL Young","year":"2014","unstructured":"Young AL, Oxtoby NP, Daga P, Cash DM, Fox NC, Ourselin S, et al. A data-driven model of biomarker changes in sporadic Alzheimer\u2019s disease. Brain. 2014;137(Pt 9):2564\u201377.","journal-title":"Brain."},{"key":"695_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/jnnp.60.1.91","volume":"60","author":"G Binetti","year":"1996","unstructured":"Binetti G, Magni E, Padovani A, Cappa SF, Bianchetti A, Trabucchi M, et al. Executive dysfunction in early Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 1996;60:91\u20133.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"695_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1017\/S135561771800022X","volume":"24","author":"JK Ho","year":"2018","unstructured":"Ho JK. Neuropsychological profiles and trajectories in preclinical Alzheimer\u2019s disease. J Int Neuropsychol Soc. 2018;24:693\u2013702.","journal-title":"J Int Neuropsychol Soc"},{"key":"695_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2016.09.002","volume-title":"Cognitive impairment and decline in cognitively normal older adults with high amyloid-\u03b2: a meta-analysis","author":"JE Baker","year":"2017","unstructured":"Baker JE, Lim YY, Pietrzak RH, Hassenstab J, Snyder PJ, Masters CL, et al. Cognitive impairment and decline in cognitively normal older adults with high amyloid-\u03b2: a meta-analysis. 2017;."},{"issue":"8","key":"695_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","volume":"71","author":"MC Donohue","year":"2014","unstructured":"Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, Thomas RG, et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014;71(8):961\u201370.","journal-title":"JAMA Neurol"},{"issue":"22","key":"695_CR32","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1001\/jama.2017.6669","volume":"317","author":"MC Donohue","year":"2017","unstructured":"Donohue MC, Sperling RA, Petersen R, Sun C-K, Weiner MW, Aisen PS. Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons. JAMA. 2017;317(22):2305.","journal-title":"JAMA."},{"issue":"9","key":"695_CR33","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jalz.2017.01.018","volume":"13","author":"EC Mormino","year":"2017","unstructured":"Mormino EC, Papp KV, Rentz DM, Donohue MC, Amariglio R, Quiroz YT, et al. Early and late change on the preclinical Alzheimer\u2019s cognitive composite in clinically normal older individuals with elevated amyloid \u03b2. Alzheimers Dement. 2017 Sep 1;13(9):1004\u201312.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"695_CR34","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/acn3.51048","volume":"7","author":"PS Insel","year":"2020","unstructured":"Insel PS, Donohue MC, Sperling R, Hansson O, Mattsson-Carlgren N. The A4 study: \u03b2-amyloid and cognition in 4432 cognitively unimpaired adults. Ann Clin Transl Neurol. 2020;7(5):776\u201385.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"695_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jalz.2017.06.2268","volume":"14","author":"KM Kinnunen","year":"2018","unstructured":"Kinnunen KM, Cash DM, Poole T, Frost C, Benzinger TLS, Ahsan RL, et al. Presymptomatic atrophy in autosomal dominant Alzheimer\u2019s disease: a serial magnetic resonance imaging study. Alzheimers Dement. 2018;14(1):43\u201353.","journal-title":"Alzheimers Dement"},{"key":"695_CR36","doi-asserted-by":"crossref","unstructured":"Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, et al. Presymptomatic hippocampal atrophy in Alzheimer\u2019s disease: a longitudinal MRI study. Brain 1996;119(6):2001\u20132007.","DOI":"10.1093\/brain\/119.6.2001"},{"issue":"12","key":"695_CR37","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jamaneurol.2017.2216","volume":"74","author":"RF Buckley","year":"2017","unstructured":"Buckley RF, Hanseeuw B, Schultz AP, Vannini P, Aghjayan SL, Properzi MJ, et al. Region-specific association of subjective cognitive decline with tauopathy independent of global \u03b2-amyloid burden. JAMA Neurol. 2017;74(12):1455.","journal-title":"JAMA Neurol."},{"key":"695_CR38","first-page":"23","volume":"5","author":"R La Joie","year":"2016","unstructured":"La Joie R, Perrotin A, Egret S, Pasquier F, Tomadesso C, M\u00e9zenge F, et al. Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: association with medical help seeking, cognitive deficits, and \u03b2-amyloid imaging. Alzheimer\u2019s Dement Diagnosis Assess Dis Monit. 2016;5:23\u201334.","journal-title":"Alzheimer\u2019s Dement Diagnosis Assess Dis Monit"},{"key":"695_CR39","first-page":"2015","volume":"2","author":"C Laske","year":"2015","unstructured":"Laske C, Sohrabi HR, Jasielec MS, M\u00fcller S, Koehler NK, Gr\u00e4ber S, et al. Diagnostic value of subjective memory complaints assessed with a single item in dominantly inherited Alzheimer\u2019s disease: results of the DIAN study. Biomed Res Int. 2015;2:2015.","journal-title":"Biomed Res Int"},{"issue":"14","key":"695_CR40","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1212\/WNL.0000000000004533","volume":"89","author":"DJ Norton","year":"2017","unstructured":"Norton DJ, Amariglio R, Protas H, Chen K, Aguirre-Acevedo DC, Pulsifer B, et al. Subjective memory complaints in preclinical autosomal dominant Alzheimer disease. Neurology. 2017;89(14):1464\u201370.","journal-title":"Neurology."},{"issue":"7","key":"695_CR41","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jalz.2015.12.013","volume":"12","author":"RF Buckley","year":"2016","unstructured":"Buckley RF, Maruff P, Ames D, Bourgeat P, Martins RN, Masters CL, et al. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2016;12(7):796\u2013804.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"695_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol. 2010;9(1):119\u201328.","journal-title":"Lancet Neurol"},{"issue":"4","key":"695_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/jnnp-2013-305078","volume":"85","author":"T Mura","year":"2014","unstructured":"Mura T, Proust-Lima C, Jacqmin-Gadda H, Akbaraly TN, Touchon J, Dubois B, et al. Measuring cognitive change in subjects with prodromal Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2014;85(4):363\u201370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"695_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/jnnp-2014-309582","volume":"87","author":"NME Scheltens","year":"2016","unstructured":"Scheltens NME, Galindo-Garre F, Pijnenburg YAL, van der Vlies AE, Smits LL, Koene T, et al. The identification of cognitive subtypes in Alzheimer\u2019s disease dementia using latent class analysis. J Neurol Neurosurg Psychiatry. 2016;87(3):235\u201343.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"695_CR45","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","volume":"9","author":"AL Young","year":"2018","unstructured":"Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and stage inference. Nat Commun. 2018;9(1):4273.","journal-title":"Nat Commun"},{"key":"695_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt155","volume":"5","author":"KL Moulder","year":"2013","unstructured":"Moulder KL, Snider BJ, Mills SL, Buckles VD, Santacruz AM, Bateman RJ, et al. Dominantly inherited alzheimer network: facilitating research and clinical trials. Alzheimer\u2019s Res Therapy. 2013;5:1\u20137.","journal-title":"Alzheimer\u2019s Res Therapy"},{"issue":"4","key":"695_CR47","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357\u201367.","journal-title":"Lancet Neurol"},{"issue":"5","key":"695_CR48","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/brain\/awy050","volume":"141","author":"NP Oxtoby","year":"2018","unstructured":"Oxtoby NP, Young AL, Cash DM, Benzinger TLS, Fagan AM, Morris JC, et al. Data-driven models of dominantly-inherited Alzheimer\u2019s disease progression. Brain. 2018;141(5):1529\u201344.","journal-title":"Brain."},{"issue":"3","key":"695_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","volume":"83","author":"DC Ryman","year":"2014","unstructured":"Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 2014;83(3):253\u201360.","journal-title":"Neurology."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00695-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00695-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00695-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T07:37:07Z","timestamp":1633505827000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00695-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00695-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Queen Square Research Ethics Committee, and all participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}